In this issue:
Predicting outcomes to optimise IBD management
Predicting response to anti-TNF therapy in IBD
Long-term outcomes of IBD in deep remission after anti-TNF-α discontinuation
Predicting low BMD in IBD
Bodyweight and composition don’t predict thiopurine metabolite levels
Liver test abnormalities predict complicated CD
Immunosuppressants/biologicals: hospitalisations and surgery in IBD
High VDBP, low albumin and remission mode predict CD relapse
Predictors of high healthcare utilisation and costs in IBD
Please login below to download this issue (PDF)